Search
Fraunhofer Institute for Toxicology and Experimental Medicine
Fraunhofer Institute for Toxicology and Experimental Medicine
Events
Press and media
Career
Contact
Deutsch
Institute
[X]
Institute
Organizational structure
Institute director
Quality assurance
Our network
Institute chronicles
Board of trustees
Mission statement
Contact persons
Coronavirus research
Services and Expertise
[X]
Services and Expertise
Drug Development
GMP manufacturing of biopharmaceuticals for clinical trials
Regulatory research and risk assessment in drug development
Preclinical research and testing
Efficacy
Toxicology testing
Clinical trials
Chemical safety and assessment
Method development and customized analyses
Toxicology testing
Exposure characterization
Regulatory risk assessment
Regulatory research
Translational Biomedical Engineering
Device development and manufacturing processes
Testing and test methods
Regulatory support
Personalized Tumor Therapy
Single-cell analytics
Enrichment, isolation and molecular analysis of rare cells
Decoding single cells
Innovative tumor models
In-vitro and in-vivo drug testing
Advanced preclinical PDX models
Mathematical modeling and bioinformatics
Multi-level disease modeling
Bioinformatics services and consulting
Focuses of Research
[X]
Focuses of Research
Drug Development
Testing of cell-based medicinal products
Controlling antibiotic-resistant pathogens
Precision Cut Lung Slices (PCLS)
Non-invasive breath gas analysis
Development of novel biomarkers for use in clinical trials
Clinical and translational fibrosis research
Imaging of the human lung - visualizing drug efficacy
Chemical Safety and Assessment
Exposure science
Toxicity of fibers, particles, and nanomaterials
Analysis of indoor and workplace air quality
Replacing animal testing
Translational Biomedical Engineering
Innovative approaches for inhaled aerosol therapies
Medical and environmental sensors
Accelerated life cycle testing
Personalized Tumor Therapy
Single-cell technologies
Identification of target structures and therapy prediction
Mathematical modeling of disease processes
Models of treatment and metastasis formation
CRC Hannover
Lighthouse projects
[X]
Lighthouse projects
High-Performance Center Translational Biomedical Engineering
German-Australian iCAIR® project: battling infection and resistance
"Phage4Cure": bacteriophages as an approved drug
EU-ToxRisk: toxicological risk assessment
Cluster of Excellence for Immune-Mediated Diseases CIMD
EU project MDOT: Open-innovation test bed to support the certification of medical devices
Mechanisms of metastasis formation
Events
[X]
Events
Looking back at “Models of Lung Disease” 2018
Looking back: 19th Fraunhofer seminar “Models of Lung Disease”
ERS International Congress 2020
Immunology Day 2020
Press and media
[X]
Press and media
Newsletter
Annual reports
Publications
Press releases
PM CPA Takeda
PM Bereich Personalisierte Tumortherapie
PM Nature Papers
Change in management 2017
Center Inauguration
New EU regulation on medical devices
eTRANSAFE – collaborative research project aimed at improving safety in the drug development process
iCAIR
Initiative Wissenschaft
Phage4Cure
German-Australian project iCAIR
Proof-of-Concept-Initiative
Fraunhofer researcher Prof. Christoph Klein received the “Fidler Innovation Award”
Science Campus 2018
InnoHealth Australia 2017-2019
Medical Device Regulation
Synergy Boost
InnoHealth Australia 2017-2019
Gentle treatment for premature babies with lung diseases
Open-innovation test bed for medical devices
Press Release iCAIR
EU-project MDOT
The EU consortium imSAVAR
Press Release iCAIR
New agents to fight multidrug-resistant germs
iCAIR® to develop new medications against SARS-CoV-2
Hunting down life-threatening metastases
Passive vaccine against COVID-19
Pancreas drug nafamostat an option for COVID-19 treatment?
Disseminated breast cancer cells use bone marrow growth factors for metastasis formation
BEAT-COVID – advanced therapy strategies against the pandemic
News
Fraunhofer ITEM scientists won prizes at the 5th DZL Annual Meeting
Poster prize to Fraunhofer ITEM scientist
Our Project Group on Personalized Tumor Therapy is now ISO 9001 certified
Testing of a novel anti-inflammatory drug for treating COPD based on endotoxin challenge
Poster prize to Fraunhofer ITEM scientist
ISO 13485 certification
Emergency use authorization of disinfectants
Sustainable Chemistry
Thematic Flyers
Career
[X]
Career
Professionals
Postgraduates
Undergraduates
Working at Fraunhofer
Contact
More
Where am I?
English
Services and Expertise
Personalized Tumor Therapy
Mathematical modeling and bioinformatics
Mathematical modeling and bioinformatics
Multi-level disease modeling
read more
Bioinformatics services and consulting
read more
Fraunhofer Institute for Toxicology and Experimental Medicine